title: Rituximab for thrombotic thrombocytopenic purpura.
authors.forename: Shaye
authors.initials: S
authors.lastname: Kivity
authors.forename: Nancy
authors.initials: N
authors.lastname: Agmon-Levin
mesh_terms: D051722:ADAM Proteins / Q000037:antagonists & inhibitors; D000071120:ADAMTS13 Protein; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000201:enzymology; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human